2001
DOI: 10.1007/bf02255976
|View full text |Cite
|
Sign up to set email alerts
|

The European acamprosate trials: Conclusions for research and therapy

Abstract: In an excellent methodological approach, the European acamprosate study project showed that acamprosate increases sobriety times. In one randomized prospective study (n = 260) comparing acamprosate and placebo, with a 1-year treatment phase and 1-year follow-up phase, the authors found that acamprosate is effective only in Lesch type I and type II patients. To investigate the possible influence of diagnostic subgrouping, we applied the Lesch typology in a co-work with the main researchers of the UK study. The … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
18
0

Year Published

2001
2001
2022
2022

Publication Types

Select...
5
4

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(19 citation statements)
references
References 31 publications
1
18
0
Order By: Relevance
“…While data are consistent with repeated withdrawals (deprivations) increasing voluntary alcohol ingestion Rodd-Henricks et al 2000a,b, 2001 or bar pressing for alcohol , inconsistencies appear to exist between these latter findings and those obtained with models of alcohol motivation. Therefore, it would seem wise to undertake future investigations to resolve these apparent differences associated with voluntary alcohol drinking, self-administration of alcohol with bar pressing and models of alcohol-seeking behavior, particularly with respect to previous repeated deprivations from chronic alcohol exposure.…”
Section: Repeated Alcohol Withdrawals and The Alcohol-deprivation Effmentioning
confidence: 81%
See 1 more Smart Citation
“…While data are consistent with repeated withdrawals (deprivations) increasing voluntary alcohol ingestion Rodd-Henricks et al 2000a,b, 2001 or bar pressing for alcohol , inconsistencies appear to exist between these latter findings and those obtained with models of alcohol motivation. Therefore, it would seem wise to undertake future investigations to resolve these apparent differences associated with voluntary alcohol drinking, self-administration of alcohol with bar pressing and models of alcohol-seeking behavior, particularly with respect to previous repeated deprivations from chronic alcohol exposure.…”
Section: Repeated Alcohol Withdrawals and The Alcohol-deprivation Effmentioning
confidence: 81%
“…Opiate antagonists (Heinälä et al 2001;Litten and Allen 1998;O'Malley et al 1992;Monti et al 2001;Rubio et al 2001;Volpicelli et al 1992), acamprosate (Ansoms et al 2000;Besson et al 1998;Chick et al 2000;Lesch et al 2001;Rubio et al 2001;Sass et al 1996;Tempesta et al 2000;Litten and Allen 1998; see overview by Mason 2001) or a combination of these drugs (Kranzler and Van Kirk 2001) are currently prescribed to reduce alcohol consumption in alcoholics. In preclinical studies, opiate antagonists are capable of minimizing acute drinking of alcohol (Altshuler et al 1980;Badia-Elder et al 1999;Froehlich et al 1990;Heyser et al 2003;Hölter and Spanagel 1999;Hyytia and Sinclair 1993;Overstreet et al 1999;Samson and Doyle 1985), as well as reducing alcohol seeking by an alcohol conditioned stimulus (Liu and Weiss 2002a;Koob et al 2003).…”
Section: Future Directionsmentioning
confidence: 99%
“…This longitudinal study verified and falsified individual items and thus filtrated criteria correlating with further illness course. Those criteria form the four subgroups of the Lesch alcoholism typology: a 'biological addiction' group with early and severe withdrawals (type I), an anxiety coping group (type II), a group with comorbidity (mainly depressive; type III) and a group with cognitive impairment prior to the development of alcoholism (type IV) [19][20][21][22][23][24]26]. The subgroups have been validated biologically and neurophysiologically [28][29][30].…”
Section: Introductionmentioning
confidence: 99%
“…Results of clinical studies testing the pharmacotherapy effects of acamprosate are very different. While some authors, especially in Europe, show clear efficacy, the opinions in the USA vary 66,67 . Thus, different effects of acamprosate were shown in various subtypes of alcoholism.…”
Section: Neuropharmacological Treatment Of Alcoholismmentioning
confidence: 99%